Loading edition detail...
Preparing this view.
Join BookitisSave favorites, build lists, and follow creators.
Preparing this view.
Douglas Braaten, David Alvaro, Azra Jaferi
"This Annals volume presents the scientific achievements by winners and finalists of the 2012 Prix Galien USA. Contributions include scholarly summaries from biopharmaceutical industry leaders (GlaxoSmithKline, MethylGene, Bristol-Myers Squibb, Novartis, Optimer Pharmaceuticals, Janssen, Bayer, Merck, UCB Pharma, Medtronic, and Novocure) on pharmaceutical advances in the treatment of a wide range of diseases including advanced melanoma, C. difficile-associated diarrhea, partial-onset seizures, chronic hepatitis C infection, recurrent glioblastoma, and thrombosis-mediated conditions, as well as advances in transcatheter valve technology and ventricular assist devices"--
| Publisher | Wiley Periodicals Inc. on behalf of the New York Academy of Sciences |
|---|---|
| Pages | 105 |
| Search language | english |
| ISBN_10 | 1-573-31916-3 primary |
| ISBN_13 | 978-1-573-31916-4 primary |
Publication-specific alternatives linked to the same work.